slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
220,801-220,830 of 319,975
16
The slide uses a process flow diagram to map out different study arms and their respective patient cohorts.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
17
The chart shows FPI-1434 Plasma AUC for two different dosing regimens.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
18
The slide highlights a specific program (Program 1) involving dual targeting of EGFR and cMET using Fusion's FastClear linker technology.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
19
The slide uses a combination of a process diagram for the in vivo study and a line chart to show efficacy results.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
20
Fusion Pharmaceuticals | Investor Presentation Deck | 30 slidesFusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
21
The slide combines financial status with a timeline of clinical milestones.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
22
Fusion Pharmaceuticals | Investor Presentation Deck | 30 slidesFusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
23
Fusion Pharmaceuticals | Investor Presentation Deck | 30 slidesFusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
24
The slide uses medical imaging (SPECT/CT) to visually demonstrate the efficacy of a pre-dose strategy in optimizing pharmacokinetics.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
25
The slide presents clinical trial data comparing pharmacokinetics and safety (thrombocytopenia) profiles.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
26
Includes specific highlighting boxes (green, yellow, red) around data subsets.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
27
Includes SPECT/CT imaging evidence and dosimetric data tables.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
28
Includes a PET/CT scan image as a case study example.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
29
The slide uses a spectrum chart to show increasing potency of toxins and a table to list advantages of TATs over ADCs.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
30
The slide uses a process diagram to show the excretion pathway and a line chart to demonstrate the 3.1x improvement in excretion rate compared to a commercial linker.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
01
Gogoro | Investor Presentation Deck | 30 slidesGogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
02
Gogoro | Investor Presentation Deck | 30 slidesGogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
03
Gogoro | Investor Presentation Deck | 30 slidesGogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
04
Gogoro | Investor Presentation Deck | 30 slidesGogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
05
GGR is the ticker symbol for Gogoro.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
06
Gogoro | Investor Presentation Deck | 30 slidesGogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
07
The slide uses a high-impact visual of electric scooters to reinforce the theme of electrification.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
08
The slide uses a 2x4 grid layout to showcase diverse company achievements.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
09
The slide uses a grid layout to present various KPIs.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
10
The slide uses a split-screen visual metaphor to contrast the two product categories.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
11
The slide uses a background image of a GoStation installation in an urban setting to contextualize the data.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
12
This is a lifestyle/brand-building slide, likely used to humanize the company and show user engagement.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
13
This slide serves as a brand partnership showcase, highlighting the aesthetic alignment between Gogoro and MUJI.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
14
This is a branding/product showcase slide, likely serving as a transition or section divider for the product portfolio.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
15
This slide serves as a brand partnership showcase, likely demonstrating Apple Wallet/Key integration.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit